Kukje Pharma Co., Ltd. (KRX:002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,685.00
-10.00 (-0.21%)
At close: Apr 29, 2025, 3:30 PM KST
-6.30%
Market Cap 94.07B
Revenue (ttm) 156.46B
Net Income (ttm) 5.21B
Shares Out 20.36M
EPS (ttm) 255.64
PE Ratio 18.07
Forward PE n/a
Dividend 30.00 (0.64%)
Ex-Dividend Date Mar 13, 2025
Volume 51,036
Average Volume 136,856
Open 4,720.00
Previous Close 4,695.00
Day's Range 4,660.00 - 4,735.00
52-Week Range 4,285.00 - 7,840.00
Beta 0.86
RSI 45.34
Earnings Date May 14, 2025

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 244
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.